DETAILED NOTES ON DO-264

quinupristin/dalfopristin will boost the degree or result of sparsentan by impacting hepatic/intestinal enzyme CYP3A4 metabolism.quinupristin/dalfopristin will enhance the level or outcome of lumateperone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Intently. Decrease lumateperone dose to 21 mg/day if coad